Bicalutamide (API – CAS 90357-06-5)

Overview

Bicalutamide is a widely used active pharmaceutical ingredient (API) in the Oncology / Anti-Androgen therapeutic category. It is supplied as a bulk pharmaceutical-grade material manufactured to meet stringent international quality standards.

Therapeutic Application

Bicalutamide is a non-steroidal anti-androgen used in combination with a luteinizing hormone-releasing hormone (LHRH) analogue for the treatment of advanced prostate cancer.

Specifications

• CAS Number: 90357-06-5
• Appearance: White to off-white crystalline powder
• Typical Assay/Purity: ≥ 99.0%
• Common Pharmacopeial Grades: USP, EP, BP, IP
• Storage: Store in a cool, dry place, away from light
• Shelf Life: Typically 24 months under recommended storage conditions

Regulatory & Compliance

Pharmint Exports adheres to WHO-GMP manufacturing practices, ensuring that Bicalutamide is produced in compliance with international quality standards. Availability of regulatory documents such as USDMF, CEP, and EU-GMP certificates, along with Certificates of Analysis (COA) and Certificates of Suitability (COS), is subject to inquiry.

Packaging & Shipping

Bicalutamide is packaged in 25kg HDPE drums with double LDPE liners, palletized for secure transport. All necessary export documentation is provided, facilitating shipping to key markets including USA, EU, Canada, Australia.

Common Use Cases & Finished Dosage Forms

This API is typically incorporated into various dosage forms including:

• Tablets
• Capsules
• Injectable solutions

Ordering Information

The minimum order quantity (MOQ) for Bicalutamide is subject to inquiry. Interested parties are encouraged to request a Certificate of Analysis (COA) and a quote via this listing. For further inquiries, please contact Pharmint Exports directly.